首页 > 最新文献

The Journal of Pathology最新文献

英文 中文
KMT2D deficiency potentiates antitumor immunity and sensitizes immune checkpoint blockade in urologic cancers KMT2D缺陷增强了泌尿系统癌症的抗肿瘤免疫并使免疫检查点阻断增敏。
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-10-06 DOI: 10.1002/path.6481
Yuedian Ye, Yuanpeng Liao, Yifan Zhang, Jianqiang Zhang, Mayao Luo, Qiao Yang, Qiliang Zhai, Zhuofan Xu, Yutong Wang, Haoran Wen, Chenwei Wu, Yang Qiu, Shidong Lv, Qiang Wei

Immune checkpoint blockade (ICB) therapy has made remarkable advances in cancer treatment. However, the overall response rate remains limited. Here, we aim to explore the role of histone 3 lysine 4 mono-methyltransferase KMT2D in tumor immune response and improve the efficacy of ICB. We developed a patient-derived urologic tumor fragment (PDUTF) platform comprising 56 tumors and constructed three major urological tumor tissue microarrays from 356 patients. Analyzed using the PDUTF platform and tissue microarrays (TMAs), we found that tumors with KMT2D deficiency were associated with enhanced T-cell activation in response to anti-PD-1 therapy and exhibited increased T-cell infiltration. Subsequently, T-cell migration and T-cell-mediated tumor cell killing assays revealed that the deletion of KMT2D in cancer cells promoted CD8+ T-cell migration and cytotoxicity against tumor cells. Mechanistically, the loss of KMT2D enhanced antitumor immunity by promoting chemokine-mediated recruitment of T cells both in vitro and in vivo. Finally, the small-molecule inhibitor MI-503 combined with anti-PD-1 therapy suppressed tumor growth on the PDUTF platform. Collectively, KMT2D deficiency sensitizes tumor cells to ICB, and inhibiting KMT2D may represent a promising approach in combination with ICB to improve patient prognosis. © 2025 The Pathological Society of Great Britain and Ireland.

免疫检查点阻断(ICB)疗法在癌症治疗方面取得了显著进展。然而,总体回复率仍然有限。本研究旨在探讨组蛋白3赖氨酸4单甲基转移酶KMT2D在肿瘤免疫应答中的作用,提高ICB的疗效。我们开发了一个患者衍生的泌尿系统肿瘤片段(PDUTF)平台,包括56个肿瘤,并构建了356例患者的三个主要泌尿系统肿瘤组织微阵列。利用PDUTF平台和组织微阵列(TMAs)进行分析,我们发现KMT2D缺陷的肿瘤在抗pd -1治疗的反应中与t细胞活化增强相关,并表现出t细胞浸润增加。随后,t细胞迁移和t细胞介导的肿瘤细胞杀伤实验显示,癌细胞中KMT2D的缺失促进了CD8+ t细胞的迁移和对肿瘤细胞的细胞毒性。在机制上,KMT2D的缺失通过促进趋化因子介导的T细胞在体外和体内的募集来增强抗肿瘤免疫。最后,小分子抑制剂MI-503联合抗pd -1治疗在PDUTF平台上抑制肿瘤生长。总的来说,KMT2D缺陷使肿瘤细胞对ICB敏感,抑制KMT2D可能是一种有希望的方法,可以联合ICB改善患者预后。©2025英国和爱尔兰病理学会。
{"title":"KMT2D deficiency potentiates antitumor immunity and sensitizes immune checkpoint blockade in urologic cancers","authors":"Yuedian Ye,&nbsp;Yuanpeng Liao,&nbsp;Yifan Zhang,&nbsp;Jianqiang Zhang,&nbsp;Mayao Luo,&nbsp;Qiao Yang,&nbsp;Qiliang Zhai,&nbsp;Zhuofan Xu,&nbsp;Yutong Wang,&nbsp;Haoran Wen,&nbsp;Chenwei Wu,&nbsp;Yang Qiu,&nbsp;Shidong Lv,&nbsp;Qiang Wei","doi":"10.1002/path.6481","DOIUrl":"10.1002/path.6481","url":null,"abstract":"<p>Immune checkpoint blockade (ICB) therapy has made remarkable advances in cancer treatment. However, the overall response rate remains limited. Here, we aim to explore the role of histone 3 lysine 4 mono-methyltransferase KMT2D in tumor immune response and improve the efficacy of ICB. We developed a patient-derived urologic tumor fragment (PDUTF) platform comprising 56 tumors and constructed three major urological tumor tissue microarrays from 356 patients. Analyzed using the PDUTF platform and tissue microarrays (TMAs), we found that tumors with KMT2D deficiency were associated with enhanced T-cell activation in response to anti-PD-1 therapy and exhibited increased T-cell infiltration. Subsequently, T-cell migration and T-cell-mediated tumor cell killing assays revealed that the deletion of <i>KMT2D</i> in cancer cells promoted CD8<sup>+</sup> T-cell migration and cytotoxicity against tumor cells. Mechanistically, the loss of KMT2D enhanced antitumor immunity by promoting chemokine-mediated recruitment of T cells both <i>in vitro</i> and <i>in vivo</i>. Finally, the small-molecule inhibitor MI-503 combined with anti-PD-1 therapy suppressed tumor growth on the PDUTF platform. Collectively, KMT2D deficiency sensitizes tumor cells to ICB, and inhibiting KMT2D may represent a promising approach in combination with ICB to improve patient prognosis. © 2025 The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 4","pages":"450-463"},"PeriodicalIF":5.2,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145230948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing homebrew AI in diagnostic practice: opportunities and barriers† 在诊断实践中推进自制人工智能:机会和障碍
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-26 DOI: 10.1002/path.6483
Zaid H Khoury, Ahmed S Sultan

In a recent issue of The Journal of Pathology, Calderaro et al present a timely and persuasive argument advocating for the integration of homebrew artificial intelligence (AI) models in diagnostic pathology. Their article is a robust defense of local model development within pathology departments as a pathway to democratizing digital diagnostics. This commentary expands on their premise, critically examining the real-world implications, practical limitations, and unmet needs of practicing pathologists. The commentary outlines both the opportunities and challenges for the widespread adoption of homebrew AI in pathology practice. Without institutional backing, digital infrastructure, and sustained training efforts, the promise of homebrew AI may falter. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

在最近一期的《病理学杂志》上,Calderaro等人提出了一个及时而有说服力的论点,主张将自制人工智能(AI)模型整合到诊断病理学中。他们的文章有力地捍卫了病理学部门内部的本地模式发展,认为这是实现数字诊断民主化的途径。这篇评论扩展了他们的前提,批判性地检查现实世界的影响,实际的限制,和未满足的需求执业病理学家。该评论概述了在病理学实践中广泛采用自制人工智能的机遇和挑战。如果没有机构支持、数字基础设施和持续的培训努力,自制人工智能的前景可能会动摇。©2025作者。《病理学杂志》由John Wiley & Sons Ltd代表大不列颠和爱尔兰病理学会出版。
{"title":"Advancing homebrew AI in diagnostic practice: opportunities and barriers†","authors":"Zaid H Khoury,&nbsp;Ahmed S Sultan","doi":"10.1002/path.6483","DOIUrl":"10.1002/path.6483","url":null,"abstract":"<p>In a recent issue of <i>The Journal of Pathology</i>, Calderaro <i>et al</i> present a timely and persuasive argument advocating for the integration of homebrew artificial intelligence (AI) models in diagnostic pathology. Their article is a robust defense of local model development within pathology departments as a pathway to democratizing digital diagnostics. This commentary expands on their premise, critically examining the real-world implications, practical limitations, and unmet needs of practicing pathologists. The commentary outlines both the opportunities and challenges for the widespread adoption of homebrew AI in pathology practice. Without institutional backing, digital infrastructure, and sustained training efforts, the promise of homebrew AI may falter. © 2025 The Author(s). <i>The Journal of Pathology</i> published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 4","pages":"371-373"},"PeriodicalIF":5.2,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pathsocjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/path.6483","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer 线粒体能量代谢失调驱动浸润性膀胱癌粘膜场效应的进展。
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-25 DOI: 10.1002/path.6474
Sangkyou Lee, Sung Yun Jung, Pawel Kuś, Jolanta Bondaruk, June Goo Lee, Roman Jaksik, Nagireddy Putluri, Khanh N Dinh, David Cogdell, Huiqin Chen, Yishan Wang, Jiansong Chen, Neema Navai, Colin Dinney, Cathy Mendelsohn, David McConkey, Richard R Behringer, Charles C Guo, Peng Wei, Marek Kimmel, Bogdan Czerniak

Multiplatform mutational and gene expression profiling complemented with proteomic and metabolomic spatial mapping were used on the whole-organ scale to identify the molecular profile of bladder cancer evolution from field effects. Analysis of the mutational landscape identified three types of mutations, referred to as α, β, and γ. Time modeling of the mutations revealed that carcinogenesis may span 30 years and can be divided into dormant and progressive phases. The α mutations developed in the dormant phase. The progressive phase lasted 5 years and was signified by expanding β mutations, but it was driven to invasive cancer by γ mutations. The mutational landscape emerged on a background of disorganized urothelial differentiation, activated epithelial-mesenchymal transition, and enhanced immune infiltration with T-cell exhaustion. Complex dysregulation of mitochondrial energy metabolism with downregulation of oxidative phosphorylation emerged as the leading mechanism driving the progression of mucosal field effects to invasive cancer. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

多平台突变和基因表达谱与蛋白质组学和代谢组学空间定位相结合,在全器官尺度上从场效应中确定膀胱癌进化的分子谱。突变景观分析确定了三种类型的突变,称为α, β和γ。突变的时间模型显示,癌变可能跨越30年,并可分为休眠和进展阶段。α突变发生在休眠期。进展期持续5年,以扩大的β突变为标志,但由γ突变驱动为侵袭性癌症。突变景观出现在尿路上皮分化紊乱、上皮-间质转化激活、免疫浸润增强和t细胞衰竭的背景下。线粒体能量代谢的复杂失调与氧化磷酸化的下调被认为是推动粘膜场效应向侵袭性癌症发展的主要机制。©2025作者。《病理学杂志》由John Wiley & Sons Ltd代表大不列颠和爱尔兰病理学会出版。
{"title":"Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer","authors":"Sangkyou Lee,&nbsp;Sung Yun Jung,&nbsp;Pawel Kuś,&nbsp;Jolanta Bondaruk,&nbsp;June Goo Lee,&nbsp;Roman Jaksik,&nbsp;Nagireddy Putluri,&nbsp;Khanh N Dinh,&nbsp;David Cogdell,&nbsp;Huiqin Chen,&nbsp;Yishan Wang,&nbsp;Jiansong Chen,&nbsp;Neema Navai,&nbsp;Colin Dinney,&nbsp;Cathy Mendelsohn,&nbsp;David McConkey,&nbsp;Richard R Behringer,&nbsp;Charles C Guo,&nbsp;Peng Wei,&nbsp;Marek Kimmel,&nbsp;Bogdan Czerniak","doi":"10.1002/path.6474","DOIUrl":"10.1002/path.6474","url":null,"abstract":"<p>Multiplatform mutational and gene expression profiling complemented with proteomic and metabolomic spatial mapping were used on the whole-organ scale to identify the molecular profile of bladder cancer evolution from field effects. Analysis of the mutational landscape identified three types of mutations, referred to as α, β, and γ. Time modeling of the mutations revealed that carcinogenesis may span 30 years and can be divided into dormant and progressive phases. The α mutations developed in the dormant phase. The progressive phase lasted 5 years and was signified by expanding β mutations, but it was driven to invasive cancer by γ mutations. The mutational landscape emerged on a background of disorganized urothelial differentiation, activated epithelial-mesenchymal transition, and enhanced immune infiltration with T-cell exhaustion. Complex dysregulation of mitochondrial energy metabolism with downregulation of oxidative phosphorylation emerged as the leading mechanism driving the progression of mucosal field effects to invasive cancer. © 2025 The Author(s). <i>The Journal of Pathology</i> published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 3","pages":"329-346"},"PeriodicalIF":5.2,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pathsocjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/path.6474","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145136122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing 利用拷贝数和靶向深度测序追踪儿童实体瘤的转移扩散。
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-23 DOI: 10.1002/path.6472
Natalie Andersson, Michele Ferro, Caroline Jansson, Subhayan Chattopadhyay, Jenny Karlsson, David Gisselsson

The most common cause of death in pediatric cancer patients is a treatment-resistant tumor, compounded by metastatic spread, making surgery, radiation therapy, and chemotherapy unfeasible as curative treatment options. However, the mechanisms behind metastatic spread in pediatric tumors remain largely unexplored. We conducted whole-genome copy number profiling on 171 primary tumor and metastases samples from 17 patients with neuroblastoma, Wilms tumor, or gonadal tumors, and performed targeted deep sequencing on a subset. Phylogenetic reconstruction enabled spatiotemporal tracking of subclones. In total, 11 of 17 patients displayed at least one metastasis arising earlier, defined as occurring before the most recent common ancestor in the primary tumor. In eight patients, metastatic spread was observed several times during tumor evolution, with different subclones from the same primary tumor having metastatic capability, even colonizing the same site. Strikingly, dissemination between metastases (intermetastatic spread) occurred in eight of nine patients with metastases in at least two different sites, indicating that this is a common phenomenon in pediatric malignancy. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

儿童癌症患者最常见的死亡原因是难治性肿瘤,再加上转移性扩散,使得手术、放疗和化疗无法作为治愈性治疗选择。然而,儿童肿瘤转移扩散背后的机制在很大程度上仍未被探索。我们对17例神经母细胞瘤、肾母细胞瘤或性腺肿瘤患者的171例原发肿瘤和转移瘤样本进行了全基因组拷贝数分析,并对一个亚群进行了靶向深度测序。系统发育重建实现了亚克隆的时空追踪。总的来说,17例患者中有11例表现出至少一种早期转移,定义为发生在原发肿瘤最近的共同祖先之前。在8例患者中,在肿瘤进化过程中多次观察到转移扩散,来自同一原发肿瘤的不同亚克隆具有转移能力,甚至定植在同一部位。引人注目的是,在至少两个不同部位转移的9例患者中,有8例发生了转移灶之间的扩散(转移间扩散),这表明这是儿童恶性肿瘤的常见现象。©2025作者。《病理学杂志》由John Wiley & Sons Ltd代表大不列颠和爱尔兰病理学会出版。
{"title":"Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing","authors":"Natalie Andersson,&nbsp;Michele Ferro,&nbsp;Caroline Jansson,&nbsp;Subhayan Chattopadhyay,&nbsp;Jenny Karlsson,&nbsp;David Gisselsson","doi":"10.1002/path.6472","DOIUrl":"10.1002/path.6472","url":null,"abstract":"<p>The most common cause of death in pediatric cancer patients is a treatment-resistant tumor, compounded by metastatic spread, making surgery, radiation therapy, and chemotherapy unfeasible as curative treatment options. However, the mechanisms behind metastatic spread in pediatric tumors remain largely unexplored. We conducted whole-genome copy number profiling on 171 primary tumor and metastases samples from 17 patients with neuroblastoma, Wilms tumor, or gonadal tumors, and performed targeted deep sequencing on a subset. Phylogenetic reconstruction enabled spatiotemporal tracking of subclones. In total, 11 of 17 patients displayed at least one metastasis arising earlier, defined as occurring before the most recent common ancestor in the primary tumor. In eight patients, metastatic spread was observed several times during tumor evolution, with different subclones from the same primary tumor having metastatic capability, even colonizing the same site. Strikingly, dissemination between metastases (intermetastatic spread) occurred in eight of nine patients with metastases in at least two different sites, indicating that this is a common phenomenon in pediatric malignancy. © 2025 The Author(s). <i>The Journal of Pathology</i> published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 3","pages":"347-365"},"PeriodicalIF":5.2,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pathsocjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/path.6472","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chromosomal instability and genomic alterations in cholangiocarcinoma from Northeastern Thailand 泰国东北部胆管癌的染色体不稳定性和基因组改变。
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-15 DOI: 10.1002/path.6464
Raksawan Deenonpoe, Molly A Guscott, Sasithorn Watcharadetwittaya, Isabel L McNeill, Daniela Moralli, Nadeem Shaikh, Sarah E McClelland

Cholangiocarcinoma (CCA) is a lethal cancer of the bile duct and is a major health concern in several parts of the world, including northeastern Thailand, where CCA incidence is the highest due to the endemic liver fluke Opisthorchis viverrini. Multiple studies have characterised genomic alterations in CCA tumours, and specific chromosomal alterations can predict prognosis. However, it is not known whether chromosomal instability (CIN), ongoing genomic alteration characteristic of most cancer types, is present in CCA tumours. In this study we leveraged a panel of cancer cell lines derived from fluke-positive CCA patients, as well as a matched normal cholangiocyte line as a control, to characterise CIN in CCA. We observed elevated rates of chromosome segregation errors compared to normal cells, although overall CIN rates were lower than those for highly genomically unstable cancers, such as colorectal or ovarian cancer. Chromosome segregation errors in CCA cell lines were potentially driven by elevated DNA replication stress and centrosome duplication. Single-cell genome sequencing and karyotyping of the cell lines showed extensive structural and numerical chromosomal aberrations, as well as copy number alterations that were heterogeneous between individual cells, supporting the presence of ongoing CIN in these cell line models. Low-pass whole-genome sequencing of 33 CCA tumour samples with matched normal tissue from northeastern Thailand, a liver fluke-endemic region showed increased whole and subchromosomal level alterations, with a higher extent of genomic alterations in intrahepatic tumours compared to extrahepatic. Eight tumours carried focal amplifications and/or deletions involving known cancer genes, as well as potential chromosomal instability-associated genes, including CCNE1 amplifications and a rare amplification of BRCA1. This study provides increased understanding of the rate and potential mechanisms of CIN in CCA that may inform new therapeutic strategies that synergise with specific ongoing CIN mechanisms. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

胆管癌(CCA)是一种致死性胆管癌,是世界上一些地区的主要健康问题,包括泰国东北部,那里的CCA发病率最高,原因是地方性的肝吸虫Opisthorchis viverrini。多项研究已经确定了CCA肿瘤的基因组改变,特定的染色体改变可以预测预后。然而,目前尚不清楚染色体不稳定性(CIN),大多数癌症类型的持续基因组改变特征,是否存在于CCA肿瘤中。在这项研究中,我们利用了一组来自吸虫阳性CCA患者的癌细胞系,以及一个匹配的正常胆管细胞系作为对照,来表征CCA中的CIN。与正常细胞相比,我们观察到染色体分离错误率升高,尽管总的CIN率低于那些高度基因组不稳定的癌症,如结直肠癌或卵巢癌。CCA细胞系的染色体分离错误可能是由DNA复制压力升高和中心体重复引起的。细胞系的单细胞基因组测序和核型分析显示了广泛的结构和染色体数量畸变,以及单个细胞之间异质性的拷贝数改变,支持这些细胞系模型中持续存在CIN。来自泰国东北部肝吸虫流行地区的33个CCA肿瘤样本与匹配的正常组织进行了低通全基因组测序,结果显示整个和亚染色体水平的改变增加,与肝外肿瘤相比,肝内肿瘤的基因组改变程度更高。8个肿瘤携带局灶扩增和/或缺失,涉及已知的癌症基因,以及潜在的染色体不稳定性相关基因,包括CCNE1扩增和罕见的BRCA1扩增。这项研究增加了对CCA中CIN的发生率和潜在机制的了解,可能为与特定的正在进行的CIN机制协同作用的新治疗策略提供信息。©2025作者。《病理学杂志》由John Wiley & Sons Ltd代表大不列颠和爱尔兰病理学会出版。
{"title":"Chromosomal instability and genomic alterations in cholangiocarcinoma from Northeastern Thailand","authors":"Raksawan Deenonpoe,&nbsp;Molly A Guscott,&nbsp;Sasithorn Watcharadetwittaya,&nbsp;Isabel L McNeill,&nbsp;Daniela Moralli,&nbsp;Nadeem Shaikh,&nbsp;Sarah E McClelland","doi":"10.1002/path.6464","DOIUrl":"10.1002/path.6464","url":null,"abstract":"<p>Cholangiocarcinoma (CCA) is a lethal cancer of the bile duct and is a major health concern in several parts of the world, including northeastern Thailand, where CCA incidence is the highest due to the endemic liver fluke <i>Opisthorchis viverrini</i>. Multiple studies have characterised genomic alterations in CCA tumours, and specific chromosomal alterations can predict prognosis. However, it is not known whether chromosomal instability (CIN), ongoing genomic alteration characteristic of most cancer types, is present in CCA tumours. In this study we leveraged a panel of cancer cell lines derived from fluke-positive CCA patients, as well as a matched normal cholangiocyte line as a control, to characterise CIN in CCA. We observed elevated rates of chromosome segregation errors compared to normal cells, although overall CIN rates were lower than those for highly genomically unstable cancers, such as colorectal or ovarian cancer. Chromosome segregation errors in CCA cell lines were potentially driven by elevated DNA replication stress and centrosome duplication. Single-cell genome sequencing and karyotyping of the cell lines showed extensive structural and numerical chromosomal aberrations, as well as copy number alterations that were heterogeneous between individual cells, supporting the presence of ongoing CIN in these cell line models. Low-pass whole-genome sequencing of 33 CCA tumour samples with matched normal tissue from northeastern Thailand, a liver fluke-endemic region showed increased whole and subchromosomal level alterations, with a higher extent of genomic alterations in intrahepatic tumours compared to extrahepatic. Eight tumours carried focal amplifications and/or deletions involving known cancer genes, as well as potential chromosomal instability-associated genes, including <i>CCNE1</i> amplifications and a rare amplification of <i>BRCA1</i>. This study provides increased understanding of the rate and potential mechanisms of CIN in CCA that may inform new therapeutic strategies that synergise with specific ongoing CIN mechanisms. © 2025 The Author(s). <i>The Journal of Pathology</i> published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 3","pages":"261-274"},"PeriodicalIF":5.2,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pathsocjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/path.6464","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145062899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periostin-IHH feedforward loop promotes hepatocellular carcinoma development by enhancing hepatic fibrosis and tumor cell proliferation 骨膜蛋白- ihh前馈环通过增强肝纤维化和肿瘤细胞增殖促进肝细胞癌的发展。
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-11 DOI: 10.1002/path.6467
Bin Liu, Xuebin Li, Menghao Zhang, Xingxing Liu, Junxing Sun, Mingjiao Deng, Gaoliang Ouyang, Tiantian Wu

The extracellular matrix protein periostin plays a critical role in the progression of hepatic fibrosis and hepatocellular carcinoma (HCC). However, little is known about how periostin regulates both hepatic fibrosis and tumor growth in the progression of HCC. Here we demonstrate that periostin deficiency impairs HCC development and decreases tissue stiffness of liver tumors in DEN/CCl4-treated mice. Increased matrix stiffness enhanced periostin expression in hepatic stellate cells (HSCs). The combination of periostin and increased stiffness synergistically promoted HCC cell proliferation in vitro. Moreover, periostin deficiency in HSCs impaired both HSC-promoted and stiffness-increased HCC cell proliferation in vivo. We further demonstrated that periostin promotes Indian hedgehog (IHH) expression in HCC cells through the integrin-PYK2-TAZ pathway. Conversely, IHH increased the expression of periostin in HSCs via GLI2. Periostin expression positively correlates with fibrotic features and IHH signaling in clinical HCC tissues. Collectively, these findings indicate that periostin and IHH cooperatively contribute to the development of HCC by regulating the tumor–stroma crosstalk via the periostin-integrin-PYK2-TAZ-IHH pathway in tumor cells and IHH-GLI2-periostin signaling in HSCs. © 2025 The Pathological Society of Great Britain and Ireland.

细胞外基质蛋白骨膜蛋白在肝纤维化和肝细胞癌(HCC)的进展中起着关键作用。然而,对于肝细胞癌进展过程中骨膜蛋白如何调节肝纤维化和肿瘤生长,我们知之甚少。本研究表明,在DEN/ ccl4处理的小鼠中,骨膜蛋白缺乏会损害HCC的发展并降低肝肿瘤的组织硬度。增加基质硬度可增强肝星状细胞(hsc)中骨膜蛋白的表达。在体外实验中,骨膜素联合僵硬度增加可协同促进HCC细胞增殖。此外,hsc中的骨膜蛋白缺乏会损害hsc促进和刚度增加的HCC细胞在体内的增殖。我们进一步证明,骨膜素通过整合素- pyk2 - taz途径促进HCC细胞中印度hedgehog基因(IHH)的表达。相反,IHH通过GLI2增加hsc中骨膜蛋白的表达。临床HCC组织中Periostin表达与纤维化特征和IHH信号正相关。总之,这些发现表明,通过肿瘤细胞中的periostin-integrin- pyk2 - taz -IHH通路和hsc中的IHH- gli2 -periostin信号通路,periostin和IHH共同调节肿瘤-间质串音,从而促进HCC的发展。©2025英国和爱尔兰病理学会。
{"title":"Periostin-IHH feedforward loop promotes hepatocellular carcinoma development by enhancing hepatic fibrosis and tumor cell proliferation","authors":"Bin Liu,&nbsp;Xuebin Li,&nbsp;Menghao Zhang,&nbsp;Xingxing Liu,&nbsp;Junxing Sun,&nbsp;Mingjiao Deng,&nbsp;Gaoliang Ouyang,&nbsp;Tiantian Wu","doi":"10.1002/path.6467","DOIUrl":"10.1002/path.6467","url":null,"abstract":"<p>The extracellular matrix protein periostin plays a critical role in the progression of hepatic fibrosis and hepatocellular carcinoma (HCC). However, little is known about how periostin regulates both hepatic fibrosis and tumor growth in the progression of HCC. Here we demonstrate that periostin deficiency impairs HCC development and decreases tissue stiffness of liver tumors in DEN/CCl<sub>4</sub>-treated mice. Increased matrix stiffness enhanced periostin expression in hepatic stellate cells (HSCs). The combination of periostin and increased stiffness synergistically promoted HCC cell proliferation <i>in vitro</i>. Moreover, periostin deficiency in HSCs impaired both HSC-promoted and stiffness-increased HCC cell proliferation <i>in vivo</i>. We further demonstrated that periostin promotes Indian hedgehog (IHH) expression in HCC cells through the integrin-PYK2-TAZ pathway. Conversely, IHH increased the expression of periostin in HSCs via GLI2. Periostin expression positively correlates with fibrotic features and IHH signaling in clinical HCC tissues. Collectively, these findings indicate that periostin and IHH cooperatively contribute to the development of HCC by regulating the tumor–stroma crosstalk via the periostin-integrin-PYK2-TAZ-IHH pathway in tumor cells and IHH-GLI2-periostin signaling in HSCs. © 2025 The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 3","pages":"275-288"},"PeriodicalIF":5.2,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145038800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the mechanisms of indocyanine green tumour uptake in sarcoma cell lines and ex vivo human tissue 研究在肉瘤细胞系和离体人体组织中吲哚菁绿肿瘤摄取的机制。
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-10 DOI: 10.1002/path.6473
Corey David Chan, Marcus J Brookes, Toni A Pringle, Rahul Pal, Riya Tanwani, Alastair D Burt, James C Knight, Anand TN Kumar, Kenneth S Rankin

Indocyanine green (ICG) is a well-established near-infrared dye which has been used clinically for several decades. Recently, it has been utilised for fluorescence-guided surgery in a range of solid cancer types, including sarcoma, with the aim of reducing the positive margin rate. The increased uptake and retention of ICG within tumours, compared with normal tissue, gives surgeons a visual reference to aid resection when viewed through a near-infrared camera. However, the mechanisms of this process are poorly understood. We performed in vitro ICG cellular uptake studies across a panel of sarcoma cell lines exhibiting varying proliferation rates and phenotypes. The effects of ICG concentration, incubation time, inhibition of clathrin-mediated endocytosis, and cell line proliferation rate on the cellular uptake of ICG were investigated using fluorescence microscopy and flow cytometry. Subcellular localisation of intracellular ICG was assessed via colocalization with a lysosomal marker. The spatial distribution of ICG in patient tumour tissue following fluorescence-guided surgery was assessed by high-resolution tissue imaging and quantified using fluorescence lifetime imaging. In vitro results showed that the cell line proliferation rate correlated significantly with ICG uptake (Spearman's rank correlation coefficient = 1.00, p < 0.001), and maximum ICG uptake was observed after 24 h incubation. ICG cellular uptake was significantly reduced by inhibition of clathrin-mediated endocytosis (p = 0.0004), and intracellular ICG significantly colocalized with a lysosomal marker within 30 min (Pearson's r = 0.8). On histological analysis of tumour tissue from three different sarcoma subtypes, ICG was observed within sarcoma cells as well as accumulating in paucicellular areas of haemorrhage and necrosis within the tumour microenvironment. Through quantification of fluorescence lifetime imaging of ICG, we were able to differentiate sarcoma cells from haemorrhage and necrosis within tumour tissue. Combining in vitro data with analysis of patient tissue, we propose that the uptake and accumulation of ICG in sarcomas is driven by a synergistic mechanism involving the enhanced permeability and retention effect combined with active tumour cell endocytosis of the dye. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

吲哚菁绿(ICG)是一种成熟的近红外染料,已在临床上使用了几十年。最近,它已被用于荧光引导的一系列实体癌类型的手术,包括肉瘤,目的是降低阳性边缘率。与正常组织相比,肿瘤中ICG的吸收和保留增加,当通过近红外摄像机观察时,为外科医生提供了辅助切除的视觉参考。然而,人们对这一过程的机制知之甚少。我们对一组表现出不同增殖率和表型的肉瘤细胞系进行了体外ICG细胞摄取研究。采用荧光显微镜和流式细胞术研究ICG浓度、培养时间、网格蛋白介导的胞吞作用抑制和细胞系增殖率对ICG细胞摄取的影响。细胞内ICG的亚细胞定位通过溶酶体标记共定位来评估。通过高分辨率组织成像评估荧光引导手术后患者肿瘤组织中ICG的空间分布,并使用荧光寿命成像进行量化。体外结果显示,细胞系增殖率与ICG摄取显著相关(Spearman秩相关系数= 1.00,p
{"title":"Investigating the mechanisms of indocyanine green tumour uptake in sarcoma cell lines and ex vivo human tissue","authors":"Corey David Chan,&nbsp;Marcus J Brookes,&nbsp;Toni A Pringle,&nbsp;Rahul Pal,&nbsp;Riya Tanwani,&nbsp;Alastair D Burt,&nbsp;James C Knight,&nbsp;Anand TN Kumar,&nbsp;Kenneth S Rankin","doi":"10.1002/path.6473","DOIUrl":"10.1002/path.6473","url":null,"abstract":"<p>Indocyanine green (ICG) is a well-established near-infrared dye which has been used clinically for several decades. Recently, it has been utilised for fluorescence-guided surgery in a range of solid cancer types, including sarcoma, with the aim of reducing the positive margin rate. The increased uptake and retention of ICG within tumours, compared with normal tissue, gives surgeons a visual reference to aid resection when viewed through a near-infrared camera. However, the mechanisms of this process are poorly understood. We performed <i>in vitro</i> ICG cellular uptake studies across a panel of sarcoma cell lines exhibiting varying proliferation rates and phenotypes. The effects of ICG concentration, incubation time, inhibition of clathrin-mediated endocytosis, and cell line proliferation rate on the cellular uptake of ICG were investigated using fluorescence microscopy and flow cytometry. Subcellular localisation of intracellular ICG was assessed <i>via</i> colocalization with a lysosomal marker. The spatial distribution of ICG in patient tumour tissue following fluorescence-guided surgery was assessed by high-resolution tissue imaging and quantified using fluorescence lifetime imaging. <i>In vitro</i> results showed that the cell line proliferation rate correlated significantly with ICG uptake (Spearman's rank correlation coefficient = 1.00, <i>p</i> &lt; 0.001), and maximum ICG uptake was observed after 24 h incubation. ICG cellular uptake was significantly reduced by inhibition of clathrin-mediated endocytosis (<i>p</i> = 0.0004), and intracellular ICG significantly colocalized with a lysosomal marker within 30 min (Pearson's <i>r</i> = 0.8). On histological analysis of tumour tissue from three different sarcoma subtypes, ICG was observed within sarcoma cells as well as accumulating in paucicellular areas of haemorrhage and necrosis within the tumour microenvironment. Through quantification of fluorescence lifetime imaging of ICG, we were able to differentiate sarcoma cells from haemorrhage and necrosis within tumour tissue. Combining <i>in vitro</i> data with analysis of patient tissue, we propose that the uptake and accumulation of ICG in sarcomas is driven by a synergistic mechanism involving the enhanced permeability and retention effect combined with active tumour cell endocytosis of the dye. © 2025 The Author(s). <i>The Journal of Pathology</i> published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 3","pages":"315-328"},"PeriodicalIF":5.2,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pathsocjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/path.6473","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145028695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cell state dynamics during early stages of serous endometrial carcinoma 浆液性子宫内膜癌早期的细胞状态动力学。
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-09 DOI: 10.1002/path.6470
Andrea Flesken-Nikitin, Matalin G Pirtz, Christopher S Ashe, Lora H Ellenson, Anna Yemelyanova, Benjamin D Cosgrove, Alexander Yu Nikitin

Serous endometrial carcinoma (SEC) is one of the most lethal types of uterine cancer, responsible for about 40% of all endometrial cancer-related deaths. Cell state dynamics during the early stages of SEC remain largely unknown, thereby hindering early detection and treatment of this disease. Here, we provide a comprehensive census of cell types and their states for normal, predysplastic, and dysplastic endometrium in a genetic mouse model of SEC. We report that predysplastic changes are characterized by increasingly diverse immature luminal epithelial cell populations. The decrease in differentiated cell states is accompanied by the emergence of a ‘single-cell and spatial transcriptome dysregulation’ gene signature. This signature contains seven genes that predict poor patient prognosis and are promising diagnostic markers and therapeutic targets. In summary, our results suggest an important role of the luminal epithelial cell state in SEC pathogenesis and validate our mouse SEC model as a capable comparative platform for preclinical studies. © 2025 The Pathological Society of Great Britain and Ireland.

浆液性子宫内膜癌(SEC)是最致命的子宫癌之一,约占所有子宫内膜癌相关死亡的40%。在早期阶段的细胞状态动力学在很大程度上仍然未知,从而阻碍了这种疾病的早期发现和治疗。在这里,我们在遗传小鼠模型中提供了正常、发育不良前和发育不良子宫内膜的细胞类型及其状态的全面普查。我们报告了发育不良前变化的特征是越来越多样化的未成熟腔上皮细胞群。分化细胞状态的减少伴随着“单细胞和空间转录组失调”基因特征的出现。该特征包含7个基因,可预测患者预后不良,是有希望的诊断标记和治疗靶点。总之,我们的研究结果表明,腔内上皮细胞状态在SEC发病机制中起重要作用,并验证了我们的小鼠SEC模型作为临床前研究的有力比较平台。©2025英国和爱尔兰病理学会。
{"title":"Cell state dynamics during early stages of serous endometrial carcinoma","authors":"Andrea Flesken-Nikitin,&nbsp;Matalin G Pirtz,&nbsp;Christopher S Ashe,&nbsp;Lora H Ellenson,&nbsp;Anna Yemelyanova,&nbsp;Benjamin D Cosgrove,&nbsp;Alexander Yu Nikitin","doi":"10.1002/path.6470","DOIUrl":"10.1002/path.6470","url":null,"abstract":"<p>Serous endometrial carcinoma (SEC) is one of the most lethal types of uterine cancer, responsible for about 40% of all endometrial cancer-related deaths. Cell state dynamics during the early stages of SEC remain largely unknown, thereby hindering early detection and treatment of this disease. Here, we provide a comprehensive census of cell types and their states for normal, predysplastic, and dysplastic endometrium in a genetic mouse model of SEC. We report that predysplastic changes are characterized by increasingly diverse immature luminal epithelial cell populations. The decrease in differentiated cell states is accompanied by the emergence of a ‘single-cell and spatial transcriptome dysregulation’ gene signature. This signature contains seven genes that predict poor patient prognosis and are promising diagnostic markers and therapeutic targets. In summary, our results suggest an important role of the luminal epithelial cell state in SEC pathogenesis and validate our mouse SEC model as a capable comparative platform for preclinical studies. © 2025 The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 3","pages":"289-303"},"PeriodicalIF":5.2,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145022530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of NLRP1 Met1154Val and IL1B variants on gestational malaria: an unexplored role of NLRP1 in inflammasome activation by Plasmodium spp. NLRP1 Met1154Val和IL1B变异对妊娠期疟疾的影响:NLRP1在疟原虫炎症小体激活中的未知作用
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-09 DOI: 10.1002/path.6471
Vinicius NC Leal, Jessica A Ribeiro, Leticia Girardi Marra, Alexandre TT Rio, Edione C Reis, Gerhard Wunderlich, Jamille G Dombrowski, Claudio RF Marinho, Alessandra Pontillo

We hypothesized that variants in inflammasome-related genes could influence susceptibility to gestational malaria (GM). To test this, we conducted an association study in a cohort of pregnant women from a malaria-endemic region in northern Brazil, assessing whether specific functional single nucleotide variants (SNVs) in inflammasome genes affect (1) the response to Plasmodium infection and (2) the development of placental malaria. Our findings revealed that the NLRP1 p.Met1154Val variant was associated with a protective effect against Plasmodium infection. Moreover, IL1B SNVs appeared more prevalent in severe cases. Additionally, multivariate analyses incorporating placental blood cytokines, growth factors, and immunohistochemical features revealed that the NLRP1 p.Met1154Val variant correlated with a healthier placental state, highlighting a potential protective role of the NLRP1 inflammasome in GM. For the first time, we showed that infected red blood cells induce NLRP1- and caspase-1-dependent pyroptosis in BeWo trophoblast cells, identifying a novel inflammasome pathway involved in GM pathogenesis. Our study identifies a genetic variant underlying NLRP1 contribution to GM and suggests that NLRP1 may be an under-explored inflammasome receptor in malaria and infected erythrocytes' sensing. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

我们假设炎症小体相关基因的变异可能影响妊娠期疟疾(GM)的易感性。为了验证这一点,我们在巴西北部疟疾流行地区的一组孕妇中进行了一项关联研究,评估炎症小体基因中的特定功能单核苷酸变异(snv)是否影响(1)对疟原虫感染的反应和(2)胎盘疟疾的发展。我们的研究结果表明,NLRP1 p.Met1154Val变异与抵抗疟原虫感染的保护作用有关。此外,IL1B snv在严重病例中更为普遍。此外,结合胎盘血液细胞因子、生长因子和免疫组织化学特征的多变量分析显示,NLRP1 p.m it1154val变异与更健康的胎盘状态相关,突出了NLRP1炎症小体在GM中的潜在保护作用。我们首次发现,感染的红细胞诱导BeWo滋养细胞NLRP1和caspase-1依赖性热亡,确定了一种参与GM发病的新型炎症小体途径。我们的研究确定了NLRP1对转基因的一种遗传变异,并表明NLRP1可能是疟疾和感染红细胞感知中未被探索的炎症小体受体。©2025作者。《病理学杂志》由John Wiley & Sons Ltd代表大不列颠和爱尔兰病理学会出版。
{"title":"Impact of NLRP1 Met1154Val and IL1B variants on gestational malaria: an unexplored role of NLRP1 in inflammasome activation by Plasmodium spp.","authors":"Vinicius NC Leal,&nbsp;Jessica A Ribeiro,&nbsp;Leticia Girardi Marra,&nbsp;Alexandre TT Rio,&nbsp;Edione C Reis,&nbsp;Gerhard Wunderlich,&nbsp;Jamille G Dombrowski,&nbsp;Claudio RF Marinho,&nbsp;Alessandra Pontillo","doi":"10.1002/path.6471","DOIUrl":"10.1002/path.6471","url":null,"abstract":"<p>We hypothesized that variants in inflammasome-related genes could influence susceptibility to gestational malaria (GM). To test this, we conducted an association study in a cohort of pregnant women from a malaria-endemic region in northern Brazil, assessing whether specific functional single nucleotide variants (SNVs) in inflammasome genes affect (1) the response to <i>Plasmodium</i> infection and (2) the development of placental malaria. Our findings revealed that the <i>NLRP1</i> p.Met1154Val variant was associated with a protective effect against <i>Plasmodium</i> infection. Moreover, <i>IL1B</i> SNVs appeared more prevalent in severe cases. Additionally, multivariate analyses incorporating placental blood cytokines, growth factors, and immunohistochemical features revealed that the <i>NLRP1</i> p.Met1154Val variant correlated with a healthier placental state, highlighting a potential protective role of the NLRP1 inflammasome in GM. For the first time, we showed that infected red blood cells induce NLRP1- and caspase-1-dependent pyroptosis in BeWo trophoblast cells, identifying a novel inflammasome pathway involved in GM pathogenesis. Our study identifies a genetic variant underlying NLRP1 contribution to GM and suggests that NLRP1 may be an under-explored inflammasome receptor in malaria and infected erythrocytes' sensing. © 2025 The Author(s). <i>The Journal of Pathology</i> published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 3","pages":"304-314"},"PeriodicalIF":5.2,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pathsocjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/path.6471","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145022602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sparking malignancy: nicotine as a driver of stemness and metastasis in triple-negative breast cancer† 引发恶性肿瘤:尼古丁在三阴性乳腺癌的发生和转移中的驱动作用
IF 5.2 2区 医学 Q1 ONCOLOGY Pub Date : 2025-09-09 DOI: 10.1002/path.6475
Christopher Simpkins, Eneda Toska

Triple-negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor (PR), and HER2, and remains one of the most aggressive and therapeutically challenging breast cancer subtypes, marked by early relapse, metastasis, and limited targeted treatment options. In a recent study published in The Journal of Pathology, Kuo et al provide compelling evidence that nicotine exposure, whether from tobacco smoke or e-cigarette vapor, drives TNBC progression by promoting stem-like and metastatic phenotypes. Integrating clinical datasets, patient tissues, cell lines, and in vivo models, the authors demonstrate that nicotine enhances tumor aggressiveness via coordinated upregulation of CHRNA9 and IGF1R. Silencing either receptor attenuates nicotine-induced stemness, invasion, and metastasis, revealing a therapeutically actionable axis. High expression of CHRNA9 and IGF1R correlates with poor clinical outcomes and may define a nicotine-exposed TNBC subgroup that could benefit from IGF1R-targeted therapy or repurposed nicotinic receptor antagonists. These findings underscore the role of environmental exposures in shaping tumor biology and offer a mechanistic basis for the poorer prognosis observed in smokers with breast cancer. © 2025 The Pathological Society of Great Britain and Ireland.

三阴性乳腺癌(TNBC)缺乏雌激素受体(ER)、孕激素受体(PR)和HER2的表达,仍然是最具侵袭性和治疗挑战性的乳腺癌亚型之一,其特点是早期复发、转移和有限的靶向治疗选择。在最近发表在《病理学杂志》上的一项研究中,Kuo等人提供了令人信服的证据,证明尼古丁暴露,无论是来自烟草烟雾还是电子烟蒸汽,都通过促进茎样和转移性表型来驱动TNBC的进展。综合临床数据集、患者组织、细胞系和体内模型,作者证明尼古丁通过协调上调CHRNA9和IGF1R来增强肿瘤的侵袭性。沉默任一受体减弱尼古丁诱导的干性、侵袭和转移,揭示出治疗上可行的轴。CHRNA9和IGF1R的高表达与不良的临床结果相关,并可能定义尼古丁暴露的TNBC亚组,该亚组可能受益于IGF1R靶向治疗或重新用途的尼古丁受体拮抗剂。这些发现强调了环境暴露在形成肿瘤生物学中的作用,并为吸烟乳腺癌患者预后较差提供了机制基础。©2025英国和爱尔兰病理学会。
{"title":"Sparking malignancy: nicotine as a driver of stemness and metastasis in triple-negative breast cancer†","authors":"Christopher Simpkins,&nbsp;Eneda Toska","doi":"10.1002/path.6475","DOIUrl":"10.1002/path.6475","url":null,"abstract":"<p>Triple-negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor (PR), and HER2, and remains one of the most aggressive and therapeutically challenging breast cancer subtypes, marked by early relapse, metastasis, and limited targeted treatment options. In a recent study published in <i>The Journal of Pathology</i>, Kuo <i>et al</i> provide compelling evidence that nicotine exposure, whether from tobacco smoke or e-cigarette vapor, drives TNBC progression by promoting stem-like and metastatic phenotypes. Integrating clinical datasets, patient tissues, cell lines, and <i>in vivo</i> models, the authors demonstrate that nicotine enhances tumor aggressiveness via coordinated upregulation of CHRNA9 and IGF1R. Silencing either receptor attenuates nicotine-induced stemness, invasion, and metastasis, revealing a therapeutically actionable axis. High expression of CHRNA9 and IGF1R correlates with poor clinical outcomes and may define a nicotine-exposed TNBC subgroup that could benefit from IGF1R-targeted therapy or repurposed nicotinic receptor antagonists. These findings underscore the role of environmental exposures in shaping tumor biology and offer a mechanistic basis for the poorer prognosis observed in smokers with breast cancer. © 2025 The Pathological Society of Great Britain and Ireland.</p>","PeriodicalId":232,"journal":{"name":"The Journal of Pathology","volume":"267 4","pages":"367-370"},"PeriodicalIF":5.2,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pathsocjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/path.6475","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145022600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Journal of Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1